Overview of Life insurance industry Date : 15.11.2017 INDEX 1. - - PowerPoint PPT Presentation

overview of life
SMART_READER_LITE
LIVE PREVIEW

Overview of Life insurance industry Date : 15.11.2017 INDEX 1. - - PowerPoint PPT Presentation

Overview of Life insurance industry Date : 15.11.2017 INDEX 1. Meaning 2. Glossary 3. Type of Life insurance 4. How they earn 5. Industry evolution 6. World Data 7. Domestic Data 8. Risk 10. Data about major private life insurers


slide-1
SLIDE 1

Overview of Life insurance industry

Date : 15.11.2017

slide-2
SLIDE 2

INDEX

  • 1. Meaning
  • 2. Glossary
  • 3. Type of Life insurance
  • 4. How they earn
  • 5. Industry evolution
  • 6. World Data
  • 7. Domestic Data
  • 8. Risk
  • 10. Data about major private life insurers
  • 11. Annexure
slide-3
SLIDE 3

Meaning 1

slide-4
SLIDE 4

Life Insurance :

Life Insurance Business means the business

  • f effecting contracts of insurance upon

human life, including any contract whereby the payment of money is assured on or the happening of any contingency dependent on human life, and any contract which is subject to payment of premiums for a term dependent on human.

slide-5
SLIDE 5

Glossary 2

slide-6
SLIDE 6

Term Description APE (Annualized Premium Equivalent) APE (Annualized Premium Equivalent) is the sum of annualized first year premiums

  • n regular premium policies, and ten percent of single premiums, on the new

business written during any period from both our individual and group customers. The APE is adjusted for any new business cancellations effected during the period. Bonus (to policyholders) The non guaranteed benefits added to a participating policy and represents the share

  • f surplus distributed to the policyholders

Expense of Management Cost or total cost refers to total expenses including commission and including provision for doubtful debts and bad debts Embedded Value (EV) The measure of the consolidated value of shareholders’ interest in the existing life insurance business. It represents the present value of shareholders’ interests in the earnings distributable from the assets allocated to the business after sufficient allowance for the aggregate risks in the business and is generally expressed as a sum

  • f Adjusted Net worth and Value of In-force of business. Embedded value

determined as per the requirements and principles prescribed in the Actuarial Practice Standard 10 issued by the Institute of Actuaries of India is referred to as Indian Embedded Value.

slide-7
SLIDE 7

Term Description Persistency Ratio The ratio of policies remaining in force to all policies issued in the period 13 month/25 month etc, prior to the date of measurement and is referred to as 13th month/25th month persistency etc It is the percentage of policies that have not discontinued paying premiums or surrendered. It can be measured in terms of number of policies or in terms of premium. Value of new business (VNB)” and “VNB margin VNB is the present value of expected future earnings from new policies written during any given period and it reflects the additional value to shareholders expected to be generated through the activity of writing new policies during any given period. VNB for any period reflects actual acquisition costs incurred during that period VNB margin is the ratio of VNB to APE for any given period and is a measure of the expected profitability of new business

slide-8
SLIDE 8

Type of Life Insurance 3

slide-9
SLIDE 9

Types of insurance Participating Participating Life Insurance Participating Pension Non- Participating (Non Linked) Term Insurance Health Insurance Endowment Annuity Non Participating (Unit Linked) Linked Life Linked Pension Linked Health

slide-10
SLIDE 10

How they earn 4

slide-11
SLIDE 11
  • Same like medicaim
  • Profit Primarily arise from

charges levied

  • n

the policyholders funds net of expenses & claims

  • Profit arise from premium and

income from investments

  • Depends on Bonus Declared

to policy holders on annual basis.

  • 1/9th
  • f

the bonus is transferred to shareholders

Participating Product Non Participating (Non linked) Health insurance Non Participating (Unit Linked)

slide-12
SLIDE 12

Industry Evolution 5

slide-13
SLIDE 13

1999-2005 2006-2011 2012-2016

  • 2000- IRDA Establishment
  • Insurance industry privatised once again
  • 26% FII permission in equity
  • Major changes in regulation of linked and non-

linked products(Reduction in commission, cap on surrender charges, increase in lock in period)

  • Licencing of Bancassurance agents
  • 49% FII permission in equity
  • Corporate agents allowed to tie up with more than
  • ne player
slide-14
SLIDE 14

Story in Chart- World Insurance Data 6

slide-15
SLIDE 15

38% 3% 23% 2% 1% 33% 58% 8% 8% 16% 1% 10% ASIA LATIN AMERICA NORTH AMERICA AFRICA OCEANIA EUROPE

WORLD LIFE INSURANCE MARKET

Life insurance market Share Population Share

slide-16
SLIDE 16

97% 93% 82% 3% 7% 18% 1995 2005 2015

LIFE INSURANCE PREMIUM MARKET SHARE

Advanced economies Emerging economies

slide-17
SLIDE 17

16.7% 16.2% 11.5% 7.2% 7.6% 7.4% 6.1% 5.5% 4.7% 3.7% 3.0% 3.5% 3.2% 3.0% 2.8% 2.7% 2.3% 2.3% 0.6% 0.5% 0.3%

LIFE INSURANCE PENETRATION AS % OF GDP

slide-18
SLIDE 18

3700.03 3598.70 3033.30 2894.50 2803.00 2227.00 2049.60 1724.90 1558.50 1150.00 616.00 353.00 298.30 298.00 222.00 195.50 46.50 22.40 21.20 9.20

LIFE INSURANCE DENSITY IN US$

slide-19
SLIDE 19

Story in Chart- Domestic Insurance Data 7

slide-20
SLIDE 20

48.10% 51.80% 51.50% 49.50% 49.40% 47.40% 59.00% 60.50% 62.60% 63.20% 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 LIFE INSURANCE COVERAGE SUM ASSURED AS % OF GDP

slide-21
SLIDE 21

LIFE INSURANCE PREMIUM HISTORY

  • Rs. In Bill.

804 1076 1348 1556 1652 1731 1798 1940 2148 2279 2429 754 930 871 1093 1258 1142 1070 1196 1131 1387 1750 1558 2006 2219 2649 2910 2873 2868 3136 3279 3666 4179 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Renewal Premium New Business Premium Total Premium

  • Expon. (Total Premium)
slide-22
SLIDE 22

29% 11% 19% 10%

  • 1%

0% 9% 5% 12% 14%

  • 5%

0% 5% 10% 15% 20% 25% 30% 35% 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

TOTAL PREMIUM GROWTH( YOY %)

slide-23
SLIDE 23

64% 54% 59% 56% 63% 76% 83% 88% 87% 87% 87% 36% 46% 41% 44% 37% 24% 17% 12% 13% 13% 13% 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

PREMIUM PROFILE

Non Linked Linked

slide-24
SLIDE 24

83% 88% 87% 86% 79% 65% 54% 45% 45% 45% 44% 17% 12% 13% 14% 21% 35% 46% 55% 55% 55% 56% 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

PRIVATE PLAYER-MIX

Linked Non Linked

slide-25
SLIDE 25

64% 50% 43% 48% 54% 63% 62% 62% 51% 48% 46% 36% 50% 57% 52% 46% 37% 38% 38% 49% 52% 54% 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

TREND IN MARKET SHARE-INDIVIDUAL WRP PREMIUM

LIC Private Sector

slide-26
SLIDE 26

72% 5% 5% 5% 3% 2% 9%

INDUSTRY MARKET SHARE TOTAL PREMIUM

LIC ICICI Pru Life HDFC Standered SBI Life Max Life Bajaj Allianz Others

slide-27
SLIDE 27

71% 4% 5% 6% 2% 2% 10%

INDUSTRY MARKET SHARE NBP

LIC ICICI Pru Life HDFC Standered SBI Life Max Life Bajaj Allianz Others

slide-28
SLIDE 28

19% 17% 18% 9% 5% 32%

PRIVATE PLAYER-MARKET SHARE TOTAL PREMIUM

ICICI Pru Life HDFC Standered SBI Life Max Life Bajaj Allianz Others 18 Players

slide-29
SLIDE 29

16% 17% 20% 7% 6% 34%

PRIVATE PLAYER-MARKET SHARE NBP

ICICI Pru Life HDFC Standered SBI Life Max Life Bajaj Allianz Others 18 Players

slide-30
SLIDE 30

Risk 8

slide-31
SLIDE 31

Changes in regulations Variation in persistency experience Interest rate fluctuations Concentration Risk

slide-32
SLIDE 32

Data of Major Private Sector Life insurers 9

slide-33
SLIDE 33

Business Performance Data of Key Private Players

Click Here : This document contains comparative analysis of five biggest private sector life insurers of India

slide-34
SLIDE 34

Annexures 10

slide-35
SLIDE 35

Sources of information :

  • 1. IRDA
  • 2. Company Reports
  • 3. Swiss Re Reports
slide-36
SLIDE 36

Basic Premium Calculation Table :

slide-37
SLIDE 37

Commission structure for regular premium based insurance products linked and non-linked : Premium paying Terms Maximum Commission or Remuneration in any form as % of premium 1st Year Renewal Premiums 5 15 7.5 6 18 7.5 7 21 7.5 8 24 7.5 9 27 7.5 10 30 7.5 11 33 7.5 12 years or more 35 7.5

slide-38
SLIDE 38

Brochure of ULIP Policy :

Click here to see the PDF of brochure

*Just for illustrative purpose only.

slide-39
SLIDE 39

Sample of financial statement of Life insurance company:

Click here to see the PDF of brochure

slide-40
SLIDE 40

Disclosure: I,/We, Jasmin Akbari authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or

  • securities. CSPL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to

the specific recommendation(s) or view(s) in this report. Research Analyst or his/her relative or CONCEPT Securities Pvt. Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or CONCEPT Securities Pvt. Ltd. or its Associate does not have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date

  • f publication of the Research Report. Further Research Analyst or his relative or CONCEPT Securities Pvt. Ltd. or its associate does not have any material conflict of interest. CONCEPT Securities Pvt. Ltd.

(CSPL) is a SEBI Registered Research Analyst having registration no. INH000002475. Disclaimer: This report has been prepared by CONCEPT Securities Pvt. Ltd. and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an

  • ffer, to buy or sell any securities or other financial instruments. This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or

entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject CSPL or its affiliates to any registration or licensing requirement within such jurisdiction. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. CSPL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments. CSPL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. CSPL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. CSPL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. CSPL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither CSPL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. CSPL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the Subject Company or third party in connection with the Research Report. This report is intended for non-Institutional Clients only. The views and opinions expressed in this report may at times be contrary to or not in consonance with those of Institutional Research or PCG Research teams of CONCEPT Securities Pvt. Ltd. and/or may have different time horizons CONCEPT Securities Pvt. Ltd., SEBI Reg. No.: NSE-INB231203531, BSE-INB011203537, SEBI Research Analyst Reg. No.: INH000002715, CIN - U25199GJ1995PTC024306